Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Celltrion (068270) – Provisional Consolidated Financial Results (Fair Disclosure) / 2025-10-21 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Execution of Sales / Supply Contract / 2026-05-04 Disclosures
  • [Disclosure] ISU PETASYS (007660) – Results of Annual General Meeting of Shareholders / 2024-03-29 Semiconductors
  • [Disclosure] Hana Micron (067310) – Additional Listing (Conversion of Domestic Private CB) / 2024-03-26 Disclosures
  • [Disclosure] Jusung Engineering (036930) – Withdrawal of Decision on Corporate Spin-off / 2024-10-29 Disclosures
  • [Disclosure] Hanmi Semiconductor (042700) – Prospects for Operating Performance on a Consolidated Basis (Fair Disclosure) / 2025-03-31 Semiconductors
  • [Disclosure] Jusung Engineering (036930) – Notice of New Listing of Stock Futures and Options (Listing of New Contract Months for Stock Futures Following Withdrawal of Corporate Spin-off) / 2024-11-14 Semiconductors
  • [Disclosure] Hyundai Motor (005380) – Decision on Disposal of Shares and Investment Certificates of Other Corporations / 2024-10-08 Disclosures

[Disclosure] Celltrion (068270) – Treasury Share Acquisition Decision / 2024-10-25

Posted on October 25, 2024August 6, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Celltrion announced its decision to acquire 537,924 common shares, valued at approximately KRW 100.0B, through direct open-market purchases.

📊 [Key Disclosure Details & Financial Highlights]

  1. Acquisition Plan Overview
  • Target Shares: 537,924 Common Shares
  • Estimated Acquisition Amount: KRW 100,000,071,600 (Approx. KRW 100.0B)
  • Expected Acquisition Period: October 28, 2024 ~ January 27, 2025
  • Purpose of Acquisition: Stock price stabilization and enhancement of shareholder value
  • Method of Acquisition: Direct open-market purchase on the KOSPI market
  • Entrusted Brokerage Firms: NH Investment & Securities Co., Ltd., Meritz Securities Co., Ltd.
  • Expected Holding Period: At least 6 months from the final acquisition date
  1. Daily Purchase Order Limit & Pricing Basis
  • Daily Purchase Order Limit: 144,904 Common Shares
  • Pricing Basis: Based on the closing stock price on the day prior to the Board resolution date (October 24, 2024: KRW 185,900); actual amounts may vary depending on future stock price fluctuations
  1. Treasury Shares Held Prior to Acquisition (As of October 25, 2024)
  • Acquired within Dividend-Paying Profits Limit: 6,091,510 Common Shares (2.8%)
  • Other Acquisitions: 4,834,777 Common Shares (2.2%)
  • Total Treasury Shares: 10,926,287 Common Shares (5.0%)
  1. Board Resolution Details
  • Board Resolution Date: October 25, 2024
  • Outside Directors Attendance: 7 Attended, 1 Absent (All audit committee members are outside directors)
  • Statutory Limit for Treasury Share Acquisition Amount: KRW 4,244,748,633,723 (Approx. KRW 4.24T)

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Tracking the Completion of Treasury Share Purchases and Subsequent Decisions

This disclosure outlines the schedule and volume for direct open-market repurchases of treasury shares. Monitoring whether the planned volume is fully repurchased within the specified timeframe, as well as tracking any subsequent decisions regarding the cancellation or disposition of the acquired shares, is important for assessing the execution of the company’s shareholder return policies. Detailed updates can be verified in the upcoming “Treasury Share Acquisition Report” and the treasury share disclosure section of future periodic reports.

📢 Disclaimer & Source Notice

Source: This content has been newly structured and created based on official submission data from the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Risk Warning: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Bio & Healthcare

Post navigation

Previous Post: [IR] SK hynix (000660 / SKHY) – Q3 2024 Earnings Presentation / 2024-10-24
Next Post: [Disclosure] Jusung Engineering (036930) – Trading Suspension and Resumption of Stock Futures / 2024-10-25

Related Posts

  • [Disclosure] Hanwha Aerospace (012450) – Setting of Record Date or Closure of Register of Shareholders / 2024-12-16 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Provisional Sales Performance / 2024-01-03 Disclosures
  • [Disclosure] ALTEOGEN (196170) – Additional Listing (Exercise of Stock Options) / 2024-10-24 Disclosures
  • [Disclosure] KEPCO (015760 / KEP) – Financial Results Disclosure Schedule Announcement / 2025-08-07 Disclosures
  • [Disclosure] PSK Holdings (031980) – Decision on Cash and In-Kind Dividend / 2026-02-20 Semiconductors
  • [Disclosure] Hana Micron (067310) – Additional Listing (Bonus Issue) / 2024-08-30 Semiconductors
  • [Disclosure] Hanmi Semiconductor (042700) – Decision on Stock Retirement / 2024-10-25 Semiconductors
  • [Disclosure] Hyundai Motor (005380) – Ex-Dividend Reference Price Notice for Interim (Quarterly) Dividend / 2025-08-27 Disclosures
  • [Disclosure] Wonik IPS (240810) – Change of Chief Executive Officer (CEO) / 2024-01-02 Semiconductors
  • [Disclosure] SK Square (402340) – Decision on Cash and In-Kind Dividend / 2024-10-29 Semiconductors
  • [Disclosure] Samsung Electro-Mechanics (009150) – Advance Notice of Earnings Release / 2024-07-10 Disclosures
  • [Disclosure] SK hynix (000660 / SKHY) – Decision on Disposal of Treasury Shares / 2025-04-23 Semiconductors
  • [Disclosure] Samsung Biologics (207940) – (Correction) Contract Signings for Supply and Sales / 2026-06-22 Disclosures
  • [Disclosure] Wonik IPS (240810) – Advance Notice of Financial Results / 2025-04-22 Semiconductors

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme